Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Inflammation × Neoadjuvant Therapy × Clear all

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 62 Colorectal Neoplasms 32 Rectal Neoplasms 31 Carcinoma, Non-Small-Cell Lung 22 Esophageal Neoplasms 21 Esophageal Squamous Cell Carcinoma 20 Pancreatic Neoplasms 15 Neoplasms 14 Adenocarcinoma Of Esophagus 12 Stomach Neoplasms 11 Lung Neoplasms 11 Carcinoma, Hepatocellular 11 Ovarian Neoplasms 10 Squamous Cell Carcinoma of Head and Neck 9 Prostatic Neoplasms 9 Neoplasm Metastasis 8 Head and Neck Neoplasms 8 Urinary Bladder Neoplasms 7 Sarcoma 7 Colonic Neoplasms 7 Uterine Cervical Neoplasms 6 Osteosarcoma 6 Recurrence 5 Multiple Myeloma 5 Fallopian Tube Neoplasms 5 Peritoneal Neoplasms 4 Nasopharyngeal Carcinoma 4 Locally Advanced Rectal Cancer 4 Inflammatory Breast Neoplasms 4 Cholangiocarcinoma 4

Interventions

Exercise 5 salicylsalicylic acid 2 palbociclib 2 Vitamin D 2 Tea 2 Tablets 2 Surgical Procedures, Operative 2 Sufentanil 2 Spironolactone 2 Resistance Training 2 Oxycodone 2 Omeprazole 2 Nutrition Assessment 2 Metformin 2 Ketorolac 2 Ibuprofen 2 Fish Oils 2 Blood Specimen Collection 2 Aspirin 2 Ascorbic Acid 2 ziprasidone 1 soybean oil, phospholipid emulsion 1 semaglutide 1 montelukast 1 microcrystalline cellulose 1 ginger extract 1 falcarinol 1 falcarindiol 1 epigallocatechin gallate 1 dapagliflozin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06447532 2025-03-12

INFLAMMATE

Federal University of São Paulo

Enrolling by invitation

Breast Neoplasms, Inflammation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡